Immunotherapy for pediatric acute lymphoblastic leukemia: recent advances and future perspectives

HIGHLIGHTS

• who: Meng Lv and collaborators from the Department of, Children`s Hospital Affiliated to Zhengzhou University, Zhengzhou, China, Department of have published the paper: Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives, in the Journal: (JOURNAL)
• what: The authors aim to provide a comprehensive overview of the emerging immunotherapeutic approaches in pediatric ALL, thus guiding the development of novel therapeutic options.
• how: The results showed that 70.2% of the patients achieved CR and 87.5% of whom were MRD negative . Preliminary results showed that none of the included acute . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.